MCM5
Showing 1 - 25 of 166
Evaluation of MCM5 in Postmenopausal Bleeding Patients
Recruiting
- Endometrial Cancer
- MCM5 ELISA
-
Manchester, United KingdomSaint Mary's Hospital, Central Manchester NHS Foundation Trust
Jan 30, 2023
Arquer's MCM5 Elisa Test to Aid in Monitoring of Recurrence in
Recruiting
- Bladder Cancer
- ADXBLADDER
-
Denver, Colorado
- +12 more
Aug 18, 2022
Diphtheria Trial in Schoenau Am Koenigssee, Milano, Santiago de Compostela (DTPa-HBV-IPV/Hib, DTaP5-HBV-IPV-Hib, Pneumococcal
Completed
- Diphtheria
- DTPa-HBV-IPV/Hib
- +2 more
-
Rosenheim, Bayern, Germany
- +19 more
Jan 24, 2023
Recurrent Vulvovaginal Candidiasis Trial in Austria, Poland, Slovakia (Prof-001, Fluconazole 150 mg, Placebo cream)
Active, not recruiting
- Recurrent Vulvovaginal Candidiasis
- Prof-001
- +3 more
-
Innsbruck, Tirol, Austria
- +28 more
Sep 21, 2022
Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis Trial in Worldwide (Humira 40 MG in Prefilled Syringe, Hulio
Recruiting
- Moderate Chronic Plaque Psoriasis
- Severe Chronic Plaque Psoriasis
- Humira 40 MG in Prefilled Syringe
- Hulio 40 MG in Prefilled Syringe / Humira 40 MG in Prefilled Syringe
-
Dupnitsa, Bulgaria
- +34 more
Jan 18, 2023
Expression of MCM5 in Urine in Patients With Urothelial Cancers
Unknown status
- Bladder Cancer
- Assessment of expression of MCM5 in the urine (ADX Bladder)
-
Warsaw, PolandMedical University of Warsaw, Dept. of Urology
Jan 3, 2019
Panic Disorder Trial in Sanxia (Mobile and Wearable-assisted Case Management)
Recruiting
- Panic Disorder
- Mobile and Wearable-assisted Case Management
-
Sanxia, New Taipei City, TaiwanEn Chu Kong Hospital
Apr 15, 2023
Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Worldwide (Betalutin)
Active, not recruiting
- Non-Hodgkin Lymphoma
- Follicular Lymphoma
-
Little Rock, Arkansas
- +95 more
Sep 9, 2022
MYFEMBREE®: A Retrospective Cohort Study UsingAdministrative
Not yet recruiting
- Pregnancy Related
- +2 more
- Relugolix + Estradiol + Norethindrone Acetate
- (no location specified)
Feb 13, 2023
Psoriasis Trial in Worldwide (PF-06826647 or Placebo, PF-06826647)
(Cost)Effectiveness of Back At Work After Surgery:Clinical
Recruiting
- Arthropathy of Knee
- Back At work After Surgery (BAAS)
-
Drachten, Friesland, NetherlandsNij Smellinghe
Jan 10, 2023
Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, HSIL Trial in Worldwide (VGX-3100, Placebo,
Completed
- Cervical Dysplasia
- +2 more
- VGX-3100
- +2 more
-
Mesa, Arizona
- +59 more
Dec 6, 2021
Alcohol Drinking, Veterans Trial in Durham (Cognitive Behavioral Therapy (CBT), Mobile Contingency Management (mCM), Long-term
Enrolling by invitation
- Alcohol Drinking
- Veterans
- Cognitive Behavioral Therapy (CBT)
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Mar 21, 2022
TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)
Active, not recruiting
- TNBC - Triple-Negative Breast Cancer
- Breast Cancer
- Trilaciclib
- +3 more
-
Birmingham, Alabama
- +111 more
Oct 25, 2022
Muscle-invasive Bladder Cancer Trial in Worldwide (Atezolizumab, Placebo)
Recruiting
- Muscle-invasive Bladder Cancer
- Atezolizumab
- Placebo
-
Santa Barbara, California
- +167 more
Mar 17, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)
Enrolling by invitation
- Chronic Lymphocytic Leukemia
- +6 more
-
Duarte, California
- +165 more
Mar 24, 2022
Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib, Rituximab, Bendamustine)
Recruiting
- Follicular Lymphoma (FL)
- +2 more
- Zandelisib
- +3 more
-
Tucson, Arizona
- +134 more
Jul 27, 2022
Bacterial Vaginosis, Vaginal Infection, Vaginal Diseases Trial in Czechia, Poland, Slovakia (Dequalinium Chloride, Metronidazole
Terminated
- Bacterial Vaginosis
- +2 more
- Dequalinium Chloride
- Metronidazole Oral
-
Brno, Czechia
- +13 more
Mar 28, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Bendamustine, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- +2 more
-
Los Angeles, California
- +142 more
Jan 10, 2023